Literature DB >> 24575238

Induction of an Antibody Response against Plasmodium falciparum F2RIIEBA by Heterologous Prime-boost Immunisation.

Rapeah Suppian1, Norazmi Mohd Nor1.   

Abstract

Heterologous prime-boost immunisation strategies can evoke powerful antibody responses and may be of value in developing an improved malaria vaccine. Herein, we show that an immunisation protocol that primes Balb/c mice with a recombinant Bacille Calmette-Guérin (rBCG) vaccine consisting of a plasmid encoding a synthetic fragment of the ESAT-6 epitope of Mycobacterium tuberculosis, the fragment 2 region II of erythrocyte-binding antigen (F2RIIEBA) and the three repeat sequences of the circumsporozoite protein (NANP)3 of Plasmodium falciparum before subsequently boosting the mice with either two doses of the rBCG clone or with a DNA vaccine expressing the native form of F2RIIEBA generating higher serum anti-F2RIIEBA antibody levels than an immunisation protocol that calls for a homologous prime-boost with two doses of rBCG. These results demonstrate the potential of DNA vaccination in boosting the antibody response to a recombinant vaccine expressing multiple epitopes.

Entities:  

Keywords:  Malaria; Plasmodium falciparum; Prime-boost; Vaccine

Year:  2013        PMID: 24575238      PMCID: PMC3799412     

Source DB:  PubMed          Journal:  Trop Life Sci Res        ISSN: 1985-3718


  30 in total

1.  Selective enhancement of systemic Th1 immunity in immunologically immature rats with an orally administered bacterial extract.

Authors:  L M Bowman; P G Holt
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein.

Authors:  Michael Walther; Fiona M Thompson; Susanna Dunachie; Sheila Keating; Stephen Todryk; Tamara Berthoud; Laura Andrews; Rikke F Andersen; Anne Moore; Sarah C Gilbert; Ian Poulton; Filip Dubovsky; Eveline Tierney; Simon Correa; Angela Huntcooke; Geoffrey Butcher; Jack Williams; Robert E Sinden; Adrian V S Hill
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit.

Authors:  Augusto Valderrama-Aguirre; Gustavo Quintero; Andrés Gómez; Alejandro Castellanos; Yobana Pérez; Fabián Méndez; Myriam Arévalo-Herrera; Sócrates Herrera
Journal:  Am J Trop Med Hyg       Date:  2005-11       Impact factor: 2.345

4.  Restriction endonuclease mapping and cloning of Mycobacterium fortuitum var. fortuitum plasmid pAL5000.

Authors:  A Labidi; H L David; D Roulland-Dussoix
Journal:  Ann Inst Pasteur Microbiol (1985)       Date:  1985 Sep-Oct

5.  Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.

Authors:  J Schneider; S C Gilbert; T J Blanchard; T Hanke; K J Robson; C M Hannan; M Becker; R Sinden; G L Smith; A V Hill
Journal:  Nat Med       Date:  1998-04       Impact factor: 53.440

6.  Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge.

Authors:  N A Doria-Rose; C Ohlen; P Polacino; C C Pierce; M T Hensel; L Kuller; T Mulvania; D Anderson; P D Greenberg; S-L Hu; N L Haigwood
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 7.  Prime-boost strategies for malaria vaccine development.

Authors:  Susanna J Dunachie; Adrian V S Hill
Journal:  J Exp Biol       Date:  2003-11       Impact factor: 3.312

Review 8.  Malaria and the red cell.

Authors:  David J Weatherall; Louis H Miller; Dror I Baruch; Kevin Marsh; Ogobara K Doumbo; Climent Casals-Pascual; David J Roberts
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2002

9.  Immunogenicity of a recombinant Mycobacterium bovis bacille Calmette-Guèrin expressing malarial and tuberculosis epitopes.

Authors:  S Rapeah; M N Norazmi
Journal:  Vaccine       Date:  2006-02-09       Impact factor: 3.641

Review 10.  Heterologous prime-boost vaccination.

Authors:  Shan Lu
Journal:  Curr Opin Immunol       Date:  2009-06-06       Impact factor: 7.486

View more
  1 in total

1.  Protective effect of a prime-boost strategy with the Ts87 vaccine against Trichinella spiralis infection in mice.

Authors:  Yuan Gu; Bin Zhan; Yaping Yang; Xiaodi Yang; Xi Zhao; Lei Wang; Jing Yang; Kuo Bi; Yunyun Wang; Xinping Zhu
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.